New FDA Commissioner Nominated by Trump Advances in Senate

President’s Trump pick to lead the U.S. Food and Drug Administration (FDA) has secured a key vote in a Senate committee, paving a way for him to advance to a full chamber vote.

Last month, President Donald Trump nominated Dr. Stephen Hahn to lead the FDA. Hahn would succeed Dr. Scott Gottlieb, who resigned earlier this year, and acting FDA Commissioner Ned Sharpless who has led the FDA since Gottlieb’s departure in April. Hahn is a well-known cancer doctor who currently serves as chief medical executive at the MD Anderson Cancer Center in Texas.

Continue Reading On: Tobacco Business Magazine